175 related articles for article (PubMed ID: 29124793)
1. Evidence for allosteric effects on p53 oligomerization induced by phosphorylation.
Muller P; Chan JM; Simoncik O; Fojta M; Lane DP; Hupp T; Vojtesek B
Protein Sci; 2018 Feb; 27(2):523-530. PubMed ID: 29124793
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
[TBL] [Abstract][Full Text] [Related]
3. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
[TBL] [Abstract][Full Text] [Related]
4. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group.
Hansen S; Hupp TR; Lane DP
J Biol Chem; 1996 Feb; 271(7):3917-24. PubMed ID: 8632013
[TBL] [Abstract][Full Text] [Related]
5. A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53.
Fraser JA; Madhumalar A; Blackburn E; Bramham J; Walkinshaw MD; Verma C; Hupp TR
J Biol Chem; 2010 Nov; 285(48):37773-86. PubMed ID: 20847049
[TBL] [Abstract][Full Text] [Related]
6. The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.
D'Abramo M; Bešker N; Desideri A; Levine AJ; Melino G; Chillemi G
Oncogene; 2016 Jun; 35(25):3272-81. PubMed ID: 26477317
[TBL] [Abstract][Full Text] [Related]
7. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
Lubin DJ; Butler JS; Loh SN
J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of different conformational states of the Sf9 cell-purified p53His175 mutant protein.
Cohen PA; Hupp TR; Lane DP; Daniels DA
FEBS Lett; 1999 Dec; 463(1-2):179-84. PubMed ID: 10601663
[TBL] [Abstract][Full Text] [Related]
9. Allosteric activation of latent p53 tetramers.
Hupp TR; Lane DP
Curr Biol; 1994 Oct; 4(10):865-75. PubMed ID: 7850419
[TBL] [Abstract][Full Text] [Related]
10. A PAb240+ conformation of wild type p53 binds DNA.
McLure KG; Lee PW
Oncogene; 1996 Sep; 13(6):1297-303. PubMed ID: 8808704
[TBL] [Abstract][Full Text] [Related]
11. The 'regulatory' beta-subunit of protein kinase CK2 negatively influences p53-mediated allosteric effects on Chk2 activation.
Bjørling-Poulsen M; Siehler S; Wiesmüller L; Meek D; Niefind K; Issinger OG
Oncogene; 2005 Sep; 24(40):6194-200. PubMed ID: 15940255
[TBL] [Abstract][Full Text] [Related]
12. Extended string binding mode of the phosphorylated transactivation domain of tumor suppressor p53.
Okuda M; Nishimura Y
J Am Chem Soc; 2014 Oct; 136(40):14143-52. PubMed ID: 25216154
[TBL] [Abstract][Full Text] [Related]
13. Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.
Krois AS; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11302-E11310. PubMed ID: 30420502
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational regulation of p53 tumor suppressor protein function.
Maxwell SA; Roth JA
Crit Rev Oncog; 1994; 5(1):23-57. PubMed ID: 7948107
[TBL] [Abstract][Full Text] [Related]
15. Investigating Conformational Dynamics and Allostery in the p53 DNA-Binding Domain Using Molecular Simulations.
Papaleo E
Methods Mol Biol; 2021; 2253():221-244. PubMed ID: 33315226
[TBL] [Abstract][Full Text] [Related]
16. Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy.
Bista M; Freund SM; Fersht AR
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15752-6. PubMed ID: 22972749
[TBL] [Abstract][Full Text] [Related]
17. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL
Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases.
Hupp TR; Lane DP
Cold Spring Harb Symp Quant Biol; 1994; 59():195-206. PubMed ID: 7587070
[TBL] [Abstract][Full Text] [Related]
19. A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.
Sun X; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443163
[TBL] [Abstract][Full Text] [Related]
20. Sliding of p53 along DNA can be modulated by its oligomeric state and by cross-talks between its constituent domains.
Khazanov N; Levy Y
J Mol Biol; 2011 Apr; 408(2):335-55. PubMed ID: 21338609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
